Insider · CIK 0001310578

Tobin Robert

Reports to the SEC for 2 companies · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001310578

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-10-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\A Award	Director	AAward	+6,000 sh	$9.18	+$55.1K	64,117
2019-10-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	0
2019-05-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+4,240 sh	$9.91	+$42K	58,117
2019-05-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,240 sh	—	—	0
2019-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Units (RSU)A Award	Director	AAward	+6,000 sh	—	—	6,000
2019-03-12	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$6.66	+$33.3K	56,568
2019-03-12	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−2,691 sh	$6.66	−$17.9K	53,877
2019-03-12	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2018-05-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+4,240 sh	—	—	4,240
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+4,286 sh	$13.65	+$58.5K	51,568
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,286 sh	—	—	0
2018-03-06	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.77	+$28.8K	49,459
2018-03-06	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−2,177 sh	$13.25	−$28.8K	47,282
2018-03-06	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	5,000
2017-06-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+4,286 sh	—	—	4,286
2017-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,282 sh	$13.50	+$71.3K	44,459
2017-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−5,282 sh	—	—	0
2017-05-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.63	+$28.2K	41,309
2017-05-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−2,132 sh	$13.20	−$28.1K	39,177
2017-05-22	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	10,000
2016-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+3,475 sh	$11.46	+$39.8K	36,309
2016-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−3,475 sh	—	—	0
2016-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+5,222 sh	—	—	5,222
2016-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+5,282 sh	—	—	5,282
2016-03-04	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$10.25	+$51.3K	35,868
2016-03-04	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−3,034 sh	$10.25	−$31.1K	32,834
2016-03-04	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · NonQualified Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	+5,000 sh	$6.22	+$31.1K	0
2015-08-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$6.85	+$68.5K	36,227
2015-08-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−5,359 sh	$12.78	−$68.5K	30,868
2015-08-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · NonQualified Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−10K sh	$6.85	−$68.5K	0
2015-07-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	+5,000 sh	$8.19	+$41K	26,227
2015-07-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Non Qualified Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−5,000 sh	$8.19	−$41K	0
2015-05-29	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+4,219 sh	$14.29	+$60.3K	21,227
2015-05-29	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,219 sh	—	—	0
2015-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+3,475 sh	—	—	3,475
2013-06-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+3,496 sh	—	—	3,496
2013-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	13,512
2013-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2013-04-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$8.86	+$44.3K	15,002
2013-04-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−3,157 sh	$14.03	−$44.3K	11,845
2013-04-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Non Qualified Stock OptionX Exercise of In-Money	Director	XExercise of In-Money	−5,000 sh	$8.86	−$44.3K	0
2012-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	10,002
2012-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2012-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$6.66	+$33.3K	65,000
2012-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2011-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	8,335
2011-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2011-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.77	+$28.8K	60,000
2011-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2010-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.63	+$28.2K	55,000

Recent filings

Accepted (ET)
Oct 164
Tobin Robert0001628280-19-012321
SEC(opens sec.gov)
May 304
Tobin Robert0001628280-19-007409
SEC(opens sec.gov)
Mar 134
Tobin Robert0001628280-19-002854
SEC(opens sec.gov)
Jun 14
Tobin Robert0001437749-18-011097
SEC(opens sec.gov)
May 254
Tobin Robert0001437749-18-010770
SEC(opens sec.gov)
Mar 84
Tobin Robert0001437749-18-004233
SEC(opens sec.gov)
Jun 54
LANDEC CORP \CA\0001437749-17-010676
SEC(opens sec.gov)
May 264
LANDEC CORP \CA\0001437749-17-010195
SEC(opens sec.gov)
May 244
LANDEC CORP \CA\0001437749-17-009958
SEC(opens sec.gov)

Companies

Address

C/O LANDEC CORPORATION 3603 HAVEN AVENUE

MENLO PARK, CA, 94025